LBA39 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck

Jean Bourhis, Yunxia Tao, C. Le Tourneau et al.|Annals of Oncology|2020

Cited by 7